v3.26.1
Statements of Cash Flows - USD ($)
 4 Months Ended 12 Months Ended
Dec. 31, 2024
Dec. 31, 2025
Cash Flows from Operating Activities:    
Net Income (Loss) $ (57,191) $ 8,916,352
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Interest earned on Investments held in the Trust Account (9,517,981)
Compensation expense incurred on the issuance of Class A shares to director nominees 400
Payment of general and administrative costs through promissory note – related party 209,241
Change in Fair Value of Overallotment liability (134,900)
Changes in operating assets and liabilities:    
Prepaid expenses (11,023)
Prepaid insurance (135,000)
Accrued expenses 31,791 45,423
Net cash used in operating activities (25,000) (627,888)
Cash Flows from Investing Activities:    
Investment of cash into Trust Account (460,000,000)
Cash withdrawn from Trust Account for working capital purposes 500,000
Net cash used in investing activities (459,500,000)
Cash Flows from Financing Activities:    
Proceeds from issuance of Class B shares to Sponsor 25,000
Proceeds from sale of Units, net of underwriting discounts paid 454,121,430
Proceeds from sale of private placement units 7,878,570
Due from Sponsor (11,695)
Proceeds from promissory note – related party 236,000
Repayment of promissory note – related party (236,000)
Payment of offering costs (768,362)
Net cash provided by financing activities 25,000 461,219,943
Net Change in Cash 1,092,055
Cash and cash equivalents – Beginning of period
Cash and cash equivalents – End of period 1,092,055
Non-Cash investing and financing activities:    
Offering costs included in accrued offering costs 362,828 (287,828)
Deferred underwriting fee payable 17,100,000
Deferred legal fee payable $ 209,200